-
Something wrong with this record ?
Normal bone turnover in transient hyperphosphatasemia
S. Kutilek, B. Cervickova, P. Bebova, M. Kmonickova, V. Nemec,
Language English Country Turkey
Document type Case Reports, Journal Article
NLK
Directory of Open Access Journals
from 2008
Free Medical Journals
from 2008
PubMed Central
from 2008
Europe PubMed Central
from 2008
Open Access Digital Library
from 2008-01-01
Medline Complete (EBSCOhost)
from 2009-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2008
PubMed
22664360
DOI
10.4274/jcrpe.680
Knihovny.cz E-resources
- MeSH
- Alkaline Phosphatase blood MeSH
- Biomarkers blood MeSH
- Infant MeSH
- Humans MeSH
- Incidental Findings MeSH
- Failure to Thrive etiology MeSH
- Diarrhea etiology MeSH
- Remission, Spontaneous MeSH
- Child Development * MeSH
- Bone Development * MeSH
- Check Tag
- Infant MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by a temporary isolated elevation of serum alkaline phosphatase activity (ALP), predominantly its bone or liver isoform, in either sick or healthy children under 5 years of age. Return to normal ALP levels usually occurs within four months. Spontaneous rise of ALP might concern the physician, especially when treating seriously ill children. However, THI is considered a benign biochemical disorder with no clinical consequences. Some existing reports support the hypothesis that THI is a result of increased bone turnover. We present evidence of normal bone turnover in two children with THI. In a one-year-old girl and a boy of the same age, high ALP levels (31 and 109 µkat/L, respectively) were accidentally detected. The children had no signs of metabolic bone disease or of liver disease. The high ALP levels returned to normal in two months, thus fulfilling the diagnosis of THI. In both patients, serum parathyroid hormone and bone turnover markers, serum CrossLaps, and serum osteocalcin were neither elevated, nor did these markers follow the ALP dynamics, thus reflecting normal bone turnover in THI. Children with THI should be spared from extensive investigations and unnecessary vitamin D treatment.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012661
- 003
- CZ-PrNML
- 005
- 20130617100619.0
- 007
- ta
- 008
- 130404s2012 tu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4274/jcrpe.680 $2 doi
- 035 __
- $a (PubMed)22664360
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a tu
- 100 1_
- $a Kutilek, Stepan $u University of Pardubice, Pardubice Hospital and Faculty of Health Studies, Pediatrics, Pardubice, Czech Republic. stepan.kutilek@nemocnice-pardubice.cz
- 245 10
- $a Normal bone turnover in transient hyperphosphatasemia / $c S. Kutilek, B. Cervickova, P. Bebova, M. Kmonickova, V. Nemec,
- 520 9_
- $a Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by a temporary isolated elevation of serum alkaline phosphatase activity (ALP), predominantly its bone or liver isoform, in either sick or healthy children under 5 years of age. Return to normal ALP levels usually occurs within four months. Spontaneous rise of ALP might concern the physician, especially when treating seriously ill children. However, THI is considered a benign biochemical disorder with no clinical consequences. Some existing reports support the hypothesis that THI is a result of increased bone turnover. We present evidence of normal bone turnover in two children with THI. In a one-year-old girl and a boy of the same age, high ALP levels (31 and 109 µkat/L, respectively) were accidentally detected. The children had no signs of metabolic bone disease or of liver disease. The high ALP levels returned to normal in two months, thus fulfilling the diagnosis of THI. In both patients, serum parathyroid hormone and bone turnover markers, serum CrossLaps, and serum osteocalcin were neither elevated, nor did these markers follow the ALP dynamics, thus reflecting normal bone turnover in THI. Children with THI should be spared from extensive investigations and unnecessary vitamin D treatment.
- 650 _2
- $a alkalická fosfatasa $x krev $7 D000469
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 12
- $a vývoj kostí $7 D001846
- 650 12
- $a vývoj dítěte $7 D002657
- 650 _2
- $a průjem $x etiologie $7 D003967
- 650 _2
- $a neprospívání $x etiologie $7 D005183
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a náhodný nález $7 D033162
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a spontánní remise $7 D012075
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cervickova, Barbora $u -
- 700 1_
- $a Bebova, Pavla $u -
- 700 1_
- $a Kmonickova, Marie $u -
- 700 1_
- $a Nemec, Vladimir $u -
- 773 0_
- $w MED00181489 $t Journal of clinical research in pediatric endocrinology $x 1308-5735 $g Roč. 4, č. 3 (2012), s. 154-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22664360 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130617101007 $b ABA008
- 999 __
- $a ok $b bmc $g 975859 $s 810942
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 4 $c 3 $d 154-6 $i 1308-5735 $m Journal of clinical research in pediatric endocrinology $n J Clin Res Pediatr Endocrinol $x MED00181489
- LZP __
- $a Pubmed-20130404